HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Murat Oztaş Selected Research

Infliximab (Remicade)

1/2008Treatment of idiopathic pyoderma gangrenosum with infliximab: induction dosing regimen or on-demand therapy?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Murat Oztaş Research Topics

Disease

1Pyoderma Gangrenosum
01/2008
1Acrodermatitis (Gianotti Crosti Syndrome)
11/2007

Drug/Important Bio-Agent (IBA)

1Infliximab (Remicade)FDA Link
01/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008
1Etanercept (Enbrel)FDA Link
11/2007

Therapy/Procedure

1Therapeutics
01/2008